What To Buy Based On The Biotech Pullback

By Jason Napodano, CFA

The IBB is down 16% from its highs. That’s probably not the bottom, but it does still represent a nice buying opportunity for long-term investors.

I look for stocks with at least 12 months cash, clean capital structures, credible management, near-term catalysts, and charismatic technology.

In my article I highlight some names that I either currently own or am thinking of buying based on this “bio-bear” market.

Please read the article on Seeking-Alpha:

More here –